TRDA
Entrada Therapeutics, Inc.Company with tickers: TRDA
CIK
1689375
CUSIP
29384C108
Shares Outstanding
38,820,616
13F Activity (30d)
105 filings
102 filers
Price
$6.49
Market Cap
$254.66M
P/E Ratio
-1.87
EPS (Diluted)
$-3.47
52W High
$16.45
52W Low
$4.93
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $875,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $43,178,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $33,054,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-42,303,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-39,717,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.95 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.95 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |